RxDoctor Payments DataLook up a doctor →

Sanjyot Bhadkamkar

Family · Mobile, ALNPI 1457778961

Payments from drug & device makers

$16,141in general payments, 2019–2025

Across 732 payments — averaging $22.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$4K
  • Merck$1K
  • AstraZeneca$951
  • Johnson & Johnson$915
  • Incyte Corporation$741
  • Pfizer$697
  • plus $8K from 54 others

What the payments were for

  • Food & beverage$13,13081%
  • Education$1141%
  • Other$2,89718%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis101$4,162
Merck53$1,038
AstraZeneca(2 entities)53$951
Johnson & Johnson44$915
Incyte Corporation40$741
Pfizer41$697
Amgen42$681
Lilly USA, LLC38$654
Eisai Inc.35$654
Daiichi Sankyo Inc.30$607
Bristol Myers Squibb22$446
Regeneron Healthcare Solutions, Inc.13$336
E.r. Squibb & Sons, L.L.C.19$330
AbbVie11$270
Genentech USA, Inc.14$261
Stemline Therapeutics Inc.11$235
Takeda Pharmaceuticals U.S.A., Inc.6$202
Astellas Pharma US Inc10$192
Sanofi9$178
Beigene USA, Inc.10$155
GSK8$153
Seagen Inc.8$145
Pharmaessentia USA Corporation6$144
Exelixis Inc.7$129
Boehringer Ingelheim5$121
Bayer6$118
Array Biopharma Inc6$116
Blueprint Medicines Corporation5$115
Deciphera Pharmaceuticals Inc.6$102
Pharmacosmos Therapeutics Inc.6$101
Gilead5$86
EMD Serono, Inc.5$82
Sumitomo Pharma America, Inc.5$80
Beone Medicines USA, Inc.4$68
CSL Behring3$66
Tempus AI, Inc4$63
Progenics Pharmaceuticals, Inc.3$58
Myovant Sciences Inc.4$52
Tersera Therapeutics LLC2$51
Puma Biotechnology, Inc.2$40
Sobi, Inc2$36
Genmab U.S., Inc.2$36
Dendreon Pharmaceuticals LLC1$35
Karyopharm Therapeutics Inc.2$35
Azurity Pharmaceuticals, Inc.2$34
Springworks Therapeutics, Inc.2$33
AVEO Pharmaceuticals, Inc.2$32
Adaptive Biotechnologies Corporation1$23
Sun Pharmaceutical Industries Inc.1$23
Pharming Healthcare, Inc.1$23
Ipsen Biopharmaceuticals, Inc1$22
Morphosys, US Inc.1$20
Paratek Pharmaceuticals, Inc.1$19
Spectrum Pharmaceuticals Inc.1$19
Novocure Inc.1$18
TG Therapeutics, Inc.1$17
Taiho Oncology, Inc.1$17
Rigel Pharmaceuticals, Inc.1$17
ADC Therapeutics America, Inc.1$16
Servier Pharmaceuticals LLC1$15

How this compares

$16,141 in reported general payments places this provider in the 95th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama

Medicare billing

Part B allowed, 2024
$31,560
Medicare patients
212
Services billed
440

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamoxifen Citrate41$1,913
Letrozole62$1,441
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen33$962
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen17$652
Potassium Chloride70$618
Anastrozole18$571
Ondansetron Hcl48$530
ValacyclovirValacyclovir Hcl11$348
Oxycodone Hcl12$221
Promethazine Hcl26$198
Gabapentin19$188
Pantoprazole Sodium19$166
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine11$106
Prednisone23$103
Levothyroxine Sodium13$33

Paid to pharmacies, not to this prescriber.

Other family in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →